Nichepharm Lifesciences Pvt. Limited is a pharmaceutical company envisaged to meet the growing demands of sterile injectable and biologics in the highly regulated markets of US and Europe and provide access to affordable medicines for the Indian subcontinent and ROW markets. As the name suggests, the company is focused to manufacture the niche and difficult to make pharmaceutical dosages leveraging the vast expertise of the promoters who have experience of over 2 decades in successfully managing and running sterile facilities.
The company is being set up as a joint venture between the Sobti Family and Recipharm AB (among the top 5 CDMOs worldwide). The partnership brings on the table brand and recognitions, market intelligence and access to world class technology and penetration to markets with huge entry barriers.
The company is headquartered at Gurgaon, Haryana and has a state-of-the-art manufacturing facility located at Selaqui Dehradun commissioned in 2021. The facility is compliant with all international regulatory authorities with a capability to manufacture a wide range of small volume parenteral and offers largest capacities in injectable space in India under one roof.
Adhering to the objective “Aiming for the next level”, Nichepharm continues to strive for excellency in all their products and service offerings customized towards meeting highest level of customer satisfaction.
-
Industry
-
Pharmaceutical Manufacturing
-
Company size
-
201-500 employees
-
Headquarters
-
Gurgaon, Haryana
-
Type
-
Privately Held
-
Founded
-
2019
-
Specialties
-
Injectables, Pre-filled Syringes, Lyophilized Injectable, Liquid Ampoules, Liquid Vials, General Dry Powder Injection, and Small Volume Parenteral
